Salemonline Journal

Creative Biolabs Optimizes One-stop Complement Therapeutics Services

 Breaking News
  • No posts were found

Creative Biolabs Optimizes One-stop Complement Therapeutics Services

March 31
17:10 2020

With more and more research focusing on complement system, the development of complement-directed drug discovery has achieved success. And as a first-class biotech manufacturer, Creative Biolabs has updated its one-stop complement therapeutics services.

Complement therapeutics have bright prospects in clinic applications for a wide spectrum of diseases. The field of complement-targeted drug discovery has experienced a profound transformation during the past decade.

With more than ten years of exploration, Creative Biolabs has been committed to bringing together highly skilled experts with varied backgrounds applicable to the research of complement-associated drugs, covering therapeutic antibodies, protease inhibitors, soluble complement regulators, complement component inhibitors and anaphylatoxin receptor antagonists.

Soluble Complement Regulator Development

With advanced technologies and long-term scientific expertise, Creative Biolabs has successfully developed a wide range of complement regulators products to meet clients’ demands precisely.

For example, Factor I (FI), also known as C3b/C4b inactivator, is a serine proteinase that is essential for regulating the complement cascade, and Creative Biolabs offers a full range of formulation development services and therapeutic drug exploration for FI related diseases, such as recurrent infections and Atypical Hemolytic Uremic Syndrome (aHUS). Factor H (FH), associated with a number of clinical implications, such as Age-related Macular Degeneration (AMD) and Ischemic Stroke by controlling the alternative pathway (AP) in blood and on cell surfaces, is another focus of Creative Biolabs.

Besides, sCR1/TP10 (Avant Immunotherapeutics) service, CAB-2/MLN-2222 (Millenium Pharmaceuticals) service and C4-binding protein (C4BP) development service are also available at Creative Biolabs.

Therapeutic Antibody Development

Following a general trend in the pharmaceutical industry, antibody-based therapeutics appears to be the most rapidly growing drug class against complement-related diseases. Based on the advanced technology, rich experience, and established complement therapeutics system, Creative Biolabs offers a comprehensive service of therapeutic antibodies development including but not limited to C5 Complement, CD20, CD46 (MCP), CD55 (DAF) and CD59 (MIRL).

Complement Test Services

Complement test is a blood test that measures the activity of a group of proteins in the bloodstream, which contributes to determining whether deficiencies or abnormalities in the complement system are occurring or contributing to the patient’s disease or condition.

At Creative Biolabs, complement function/activity test, complement autoantibody test and complement genetic test are all performed to help diagnose, monitor and treat immune diseases and immune complex-related conditions, as well as helping develop new complement-targeted therapies.

“Our services are highly qualified, reliable and most importantly, customized.” Introduced by a senior scientist at Creative Biolabs, “For example, last few years, we have won reputations in several cases about complement-related infection services, including septic shock, meningococcal meningitis and chemotherapy-induced neutropenia.”

Creative Biolabs offers a broad and integrated portfolio of laboratory and manufacturing services for complement therapeutic. Apart from the aforementioned services, a series of off-the-shelf complement therapeutic products, ranging from antibodies, recombinant proteins, peptides to array kits are also provided.

For more information, please visit https://www.creative-biolabs.com/complement-therapeutics.

About Creative Biolabs

With an unrelenting drive in the biotechnology research area, Creative Biolabs has organized professional Ph.D.-level research teams, who are working closely with each other to meet the special project requirements in the quality and timeline. Creative Biolabs is always dedicated to satisfying the needs of clients covering more than 50 countries and districts.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Country: United States
Website: https://www.creative-biolabs.com